{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T23:35:22Z","timestamp":1776987322472,"version":"3.51.4"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,23]]},"DOI":"10.7759\/cureus.107610","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T22:51:52Z","timestamp":1776984712000},"source":"Crossref","is-referenced-by-count":0,"title":["Gatekeepers of Pain: A Scoping Review on How Nanoparticle Engineering Illuminates Selective Transient Receptor Potential Vanilloid 1 (TRPV1) Targeting"],"prefix":"10.7759","author":[{"given":"Alexa Q","family":"Xiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiffany","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikita","family":"Balraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shadi","family":"Abu-Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresrev.2008.12.006","article-title":"Therapeutic potential of vanilloid receptor TRPV1 agonists and antagonists as analgesics: recent advances and setbacks","volume":"60","author":"Wong GY","year":"2009","unstructured":"Wong GY, Gavva NR. Therapeutic potential of vanilloid receptor TRPV1 agonists and antagonists as analgesics: recent advances and setbacks. Brain Res Rev. 2009, 60:267-77. 10.1016\/j.brainresrev.2008.12.006","journal-title":"Brain Res Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/md11125100","article-title":"Polypeptide modulators of TRPV1 produce analgesia without hyperthermia","volume":"11","author":"Andreev YA","year":"2013","unstructured":"Andreev YA, Kozlov SA, Korolkova YV, et al.. Polypeptide modulators of TRPV1 produce analgesia without hyperthermia. Mar Drugs. 2013, 11:5100-15. 10.3390\/md11125100","journal-title":"Mar Drugs"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1124\/pr.109.001263","article-title":"The transient receptor potential vanilloid-1 channel in thermoregulation: a thermosensor it is not","volume":"61","author":"Romanovsky AA","year":"2009","unstructured":"Romanovsky AA, Almeida MC, Garami A, et al.. The transient receptor potential vanilloid-1 channel in thermoregulation: a thermosensor it is not. Pharmacol Rev. 2009, 61:228-61. 10.1124\/pr.109.001263","journal-title":"Pharmacol Rev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/cl2.1230","article-title":"PRISMA2020: an R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and open synthesis","volume":"18","author":"Haddaway NR","year":"2022","unstructured":"Haddaway NR, Page MJ, Pritchard CC, McGuinness LA. PRISMA2020: an R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and open synthesis. Campbell Syst Rev. 2022, 18:e1230. 10.1002\/cl2.1230","journal-title":"Campbell Syst Rev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco AC","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, et al.. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018, 169:467-73. 10.7326\/M18-0850","journal-title":"Ann Intern Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.121524","article-title":"Potential use for chronic pain: poly(ethylene glycol)-poly(lactic-co-glycolic acid) nanoparticles enhance the effects of cannabis-based terpenes on calcium influx in TRPV1-expressing cells","volume":"616","author":"El-Hammadi MM","year":"2022","unstructured":"El-Hammadi MM, Small-Howard AL, Jansen C, Fern\u00e1ndez-Ar\u00e9valo M, Turner H, Mart\u00edn-Banderas L. Potential use for chronic pain: poly(ethylene glycol)-poly(lactic-co-glycolic acid) nanoparticles enhance the effects of cannabis-based terpenes on calcium influx in TRPV1-expressing cells. Int J Pharm. 2022, 616:121524. 10.1016\/j.ijpharm.2022.121524","journal-title":"Int J Pharm"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122954","article-title":"Current insights and therapeutic strategies for targeting TRPV1 in neuropathic pain management","volume":"355","author":"Rahman MM","year":"2024","unstructured":"Rahman MM, Jo YY, Kim YH, Park CK. Current insights and therapeutic strategies for targeting TRPV1 in neuropathic pain management. Life Sci. 2024, 355:122954. 10.1016\/j.lfs.2024.122954","journal-title":"Life Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-0348-0828-6_5","article-title":"Capsaicin-based therapies for pain control","volume":"68","author":"Smith H","year":"2014","unstructured":"Smith H, Brooks JR. Capsaicin-based therapies for pain control. Prog Drug Res. 2014, 68:129-46. 10.1007\/978-3-0348-0828-6_5","journal-title":"Prog Drug Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-008-9750-5","article-title":"The functional regulation of TRPV1 and its role in pain sensitization","volume":"33","author":"Wang Y","year":"2008","unstructured":"Wang Y. The functional regulation of TRPV1 and its role in pain sensitization. Neurochem Res. 2008, 33:2008-12. 10.1007\/s11064-008-9750-5","journal-title":"Neurochem Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/978-94-007-0265-3_34","article-title":"TRPV1: a therapy target that attracts the pharmaceutical interests","volume":"704","author":"Xia R","year":"2011","unstructured":"Xia R, Dekermendjian K, Lullau E, Dekker N. TRPV1: a therapy target that attracts the pharmaceutical interests. Adv Exp Med Biol. 2011, 704:637-65. 10.1007\/978-94-007-0265-3_34","journal-title":"Adv Exp Med Biol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2006.09.001","article-title":"TRPV1: a therapeutic target for novel analgesic drugs?","volume":"12","author":"Szallasi A","year":"2006","unstructured":"Szallasi A, Cruz F, Geppetti P. TRPV1: a therapeutic target for novel analgesic drugs?. Trends Mol Med. 2006, 12:545-54. 10.1016\/j.molmed.2006.09.001","journal-title":"Trends Mol Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.104.082487","article-title":"Role of transient receptor potential vanilloid 1 receptors in adjuvant-induced chronic arthritis: in vivo study using gene-deficient mice","volume":"314","author":"Szab\u00f3 A","year":"2005","unstructured":"Szab\u00f3 A, Helyes Z, S\u00e1ndor K, et al.. Role of transient receptor potential vanilloid 1 receptors in adjuvant-induced chronic arthritis: in vivo study using gene-deficient mice. J Pharmacol Exp Ther. 2005, 314:111-9. 10.1124\/jpet.104.082487","journal-title":"J Pharmacol Exp Ther"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1517\/13543776.18.2.159","article-title":"Advances in the design and therapeutic use of capsaicin receptor TRPV1 agonists and antagonists","volume":"18","author":"Gharat LA","year":"2008","unstructured":"Gharat LA, Szallasi A. Advances in the design and therapeutic use of capsaicin receptor TRPV1 agonists and antagonists. Expert Opin Ther Pat. 2008, 18:159-209. 10.1517\/13543776.18.2.159","journal-title":"Expert Opin Ther Pat"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1018550108","article-title":"Activity-dependent targeting of TRPV1 with a pore-permeating capsaicin analog","volume":"108","author":"Li H","year":"2011","unstructured":"Li H, Wang S, Chuang AY, Cohen BE, Chuang HH. Activity-dependent targeting of TRPV1 with a pore-permeating capsaicin analog. Proc Natl Acad Sci U S A. 2011, 108:8497-502. 10.1073\/pnas.1018550108","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/bph.14676","article-title":"Analgesic transient receptor potential vanilloid-1-active compounds inhibit native and recombinant T-type calcium channels","volume":"176","author":"McArthur JR","year":"2019","unstructured":"McArthur JR, Finol-Urdaneta RK, Adams DJ. Analgesic transient receptor potential vanilloid-1-active compounds inhibit native and recombinant T-type calcium channels. Br J Pharmacol. 2019, 176:2264-78. 10.1111\/bph.14676","journal-title":"Br J Pharmacol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2017.00272","article-title":"TRPA1 channels modify TRPV1-mediated current responses in dorsal root ganglion neurons","volume":"8","author":"Masuoka T","year":"2017","unstructured":"Masuoka T, Kudo M, Yamashita Y, et al.. TRPA1 channels modify TRPV1-mediated current responses in dorsal root ganglion neurons. Front Physiol. 2017, 8:272. 10.3389\/fphys.2017.00272","journal-title":"Front Physiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12040339","article-title":"Lipid nanoparticle inclusion prevents capsaicin-induced TRPV1 defunctionalization","volume":"12","author":"Puglia C","year":"2020","unstructured":"Puglia C, Santonocito D, Bonaccorso A, et al.. Lipid nanoparticle inclusion prevents capsaicin-induced TRPV1 defunctionalization. Pharmaceutics. 2020, 12:9. 10.3390\/pharmaceutics12040339","journal-title":"Pharmaceutics"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1124\/mol.113.088997","article-title":"Modulation of transient receptor vanilloid 1 activity by transient receptor potential ankyrin 1","volume":"85","author":"Spahn V","year":"2014","unstructured":"Spahn V, Stein C, Z\u00f6llner C. Modulation of transient receptor vanilloid 1 activity by transient receptor potential ankyrin 1. Mol Pharmacol. 2014, 85:335-44. 10.1124\/mol.113.088997","journal-title":"Mol Pharmacol"},{"key":"ref19","article-title":"Ca2+ and calpain mediate capsaicin-induced ablation of axonal terminals expressing transient receptor potential vanilloid 1","volume":"292","author":"Wang S","year":"2017","unstructured":"Wang S, Asgar J, Joseph J, et al.. Ca2+ and calpain mediate capsaicin-induced ablation of axonal terminals expressing transient receptor potential vanilloid 1. J Biol Chem. 2017, 292:8291-303.","journal-title":"J Biol Chem"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/4861491","article-title":"Pirt together with TRPV1 is involved in the regulation of neuropathic pain","volume":"2018","author":"Wang C","year":"2018","unstructured":"Wang C, Gu L, Ruan Y, et al.. Pirt together with TRPV1 is involved in the regulation of neuropathic pain. Neural Plast. 2018, 2018:9. 10.1155\/2018\/4861491","journal-title":"Neural Plast"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34817-1","article-title":"Structure-guided peptide engineering of a positive allosteric modulator targeting the outer pore of TRPV1 for long-lasting analgesia","volume":"14","author":"Zhang H","year":"2023","unstructured":"Zhang H, Lin JJ, Xie YK, et al.. Structure-guided peptide engineering of a positive allosteric modulator targeting the outer pore of TRPV1 for long-lasting analgesia. Nat Commun. 2023, 14:4. 10.1038\/s41467-022-34817-1","journal-title":"Nat Commun"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1097\/PR9.0000000000000922","article-title":"Transient receptor potential vanilloid subtype 1 depletion mediates mechanical allodynia through cellular signal alterations in small-fiber neuropathy","volume":"6","author":"Chang CH","year":"2021","unstructured":"Chang CH, Chang YS, Hsieh YL. Transient receptor potential vanilloid subtype 1 depletion mediates mechanical allodynia through cellular signal alterations in small-fiber neuropathy. Pain Rep. 2021, 6:e922. 10.1097\/PR9.0000000000000922","journal-title":"Pain Rep"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2024.102447","article-title":"Targeting TRP channels for pain relief: a review of current evidence from bench to bedside","volume":"75","author":"Koivisto AP","year":"2024","unstructured":"Koivisto AP, Voets T, Iadarola MJ, Szallasi A. Targeting TRP channels for pain relief: a review of current evidence from bench to bedside. Curr Opin Pharmacol. 2024, 75:102447. 10.1016\/j.coph.2024.102447","journal-title":"Curr Opin Pharmacol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/bph.14044","article-title":"Targeting nociceptive transient receptor potential channels to treat chronic pain: current state of the field","volume":"175","author":"Moran MM","year":"2018","unstructured":"Moran MM, Szallasi A. Targeting nociceptive transient receptor potential channels to treat chronic pain: current state of the field. Br J Pharmacol. 2018, 175:2185-203. 10.1111\/bph.14044","journal-title":"Br J Pharmacol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26040778","article-title":"Injectable capsaicin for the management of pain due to osteoarthritis","volume":"26","author":"Campbell JN","year":"2021","unstructured":"Campbell JN, Stevens R, Hanson P, Connolly J, Meske DS, Chung MK, Lascelles BD. Injectable capsaicin for the management of pain due to osteoarthritis. Molecules. 2021, 26:8. 10.3390\/molecules26040778","journal-title":"Molecules"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3390\/ph9030052","article-title":"TRPV1: a target for rational drug design","volume":"9","author":"Carnevale V","year":"2016","unstructured":"Carnevale V, Rohacs T. TRPV1: a target for rational drug design. Pharmaceuticals (Basel). 2016, 9:2. 10.3390\/ph9030052","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S12978","article-title":"Role of the transient receptor potential vanilloid 1 in inflammation and sepsis","volume":"4","author":"Devesa I","year":"2011","unstructured":"Devesa I, Planells-Cases R, Fern\u00e1ndez-Ballester G, Gonz\u00e1lez-Ros JM, Ferrer-Montiel A, Fern\u00e1ndez-Carvajal A. Role of the transient receptor potential vanilloid 1 in inflammation and sepsis. J Inflamm Res. 2011, 4:67-81. 10.2147\/JIR.S12978","journal-title":"J Inflamm Res"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1211\/jpp.59.5.0015","article-title":"Differential involvement of TRPV1 receptors at the central and peripheral nerves in CFA-induced mechanical and thermal hyperalgesia","volume":"59","author":"Kanai Y","year":"2007","unstructured":"Kanai Y, Hara T, Imai A, Sakakibara A. Differential involvement of TRPV1 receptors at the central and peripheral nerves in CFA-induced mechanical and thermal hyperalgesia. J Pharm Pharmacol. 2007, 59:733-8. 10.1211\/jpp.59.5.0015","journal-title":"J Pharm Pharmacol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.34133\/research.0316","article-title":"Bifunctional TRPV1 targeted magnetothermal switch to attenuate osteoarthritis progression","volume":"7","author":"Lv Z","year":"2024","unstructured":"Lv Z, Wang P, Li W, et al.. Bifunctional TRPV1 targeted magnetothermal switch to attenuate osteoarthritis progression. Research (Wash D C). 2024, 7:0316. 10.34133\/research.0316","journal-title":"Research (Wash D C)"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S153671","article-title":"Peripheral and spinal TRPA1 channels contribute to formalin-induced long-lasting mechanical hypersensitivity","volume":"11","author":"Mart\u00ednez-Rojas VA","year":"2018","unstructured":"Mart\u00ednez-Rojas VA, Garc\u00eda G, Noriega-Navarro R, Guzm\u00e1n-Priego CG, Torres-L\u00f3pez JE, Granados-Soto V, Murbarti\u00e1n J. Peripheral and spinal TRPA1 channels contribute to formalin-induced long-lasting mechanical hypersensitivity. J Pain Res. 2018, 11:51-60. 10.2147\/JPR.S153671","journal-title":"J Pain Res"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22073712","article-title":"Hypersensitivity induced by intrathecal bradykinin administration is enhanced by N-oleoyldopamine (OLDA) and prevented by TRPV1 antagonist","volume":"22","author":"Uchytilova E","year":"2021","unstructured":"Uchytilova E, Spicarova D, Palecek J. Hypersensitivity induced by intrathecal bradykinin administration is enhanced by N-oleoyldopamine (OLDA) and prevented by TRPV1 antagonist. Int J Mol Sci. 2021, 22:2. 10.3390\/ijms22073712","journal-title":"Int J Mol Sci"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1097\/WNR.0000000000000322","article-title":"The role of TRPV1 channels in carrageenan-induced mechanical hyperalgesia in mice","volume":"26","author":"Watanabe M","year":"2015","unstructured":"Watanabe M, Ueda T, Shibata Y, Kumamoto N, Ugawa S. The role of TRPV1 channels in carrageenan-induced mechanical hyperalgesia in mice. Neuroreport. 2015, 26:173-8. 10.1097\/WNR.0000000000000322","journal-title":"Neuroreport"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1124\/mol.106.026740","article-title":"Mu-opioid receptor activation modulates transient receptor potential vanilloid 1 (TRPV1) currents in sensory neurons in a model of inflammatory pain","volume":"71","author":"Endres-Becker J","year":"2007","unstructured":"Endres-Becker J, Heppenstall PA, Mousa SA, et al.. Mu-opioid receptor activation modulates transient receptor potential vanilloid 1 (TRPV1) currents in sensory neurons in a model of inflammatory pain. Mol Pharmacol. 2007, 71:12-8. 10.1124\/mol.106.026740","journal-title":"Mol Pharmacol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2012.07.022","article-title":"Involvement of the glutamatergic system in the nociception induced intrathecally for a TRPA1 agonist in rats","volume":"222","author":"Klafke JZ","year":"2012","unstructured":"Klafke JZ, da Silva MA, Trevisan G, et al.. Involvement of the glutamatergic system in the nociception induced intrathecally for a TRPA1 agonist in rats. Neuroscience. 2012, 222:136-46. 10.1016\/j.neuroscience.2012.07.022","journal-title":"Neuroscience"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.4161\/chan.5.6.18016","article-title":"The role of TRPA1 in visceral inflammation and pain","volume":"5","author":"Lapointe TK","year":"2011","unstructured":"Lapointe TK, Altier C. The role of TRPA1 in visceral inflammation and pain. Channels (Austin). 2011, 5:525-9. 10.4161\/chan.5.6.18016","journal-title":"Channels (Austin)"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/5806321","article-title":"Multifunctional TRPV1 ion channels in physiology and pathology with focus on the brain, vasculature, and visceral systems","volume":"2019","author":"Storozhuk MV","year":"2019","unstructured":"Storozhuk MV, Moroz OF, Zholos AV. Multifunctional TRPV1 ion channels in physiology and pathology with focus on the brain, vasculature, and visceral systems. Biomed Res Int. 2019, 2019:2. 10.1155\/2019\/5806321","journal-title":"Biomed Res Int"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.23-14-06058.2003","article-title":"Possible involvement of P2Y2 metabotropic receptors in ATP-induced transient receptor potential vanilloid receptor 1-mediated thermal hypersensitivity","volume":"23","author":"Moriyama T","year":"2003","unstructured":"Moriyama T, Iida T, Kobayashi K, et al.. Possible involvement of P2Y2 metabotropic receptors in ATP-induced transient receptor potential vanilloid receptor 1-mediated thermal hypersensitivity. J Neurosci. 2003, 23:6058-62. 10.1523\/JNEUROSCI.23-14-06058.2003","journal-title":"J Neurosci"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1523\/ENEURO.0118-20.2020","article-title":"Ablation of TRPV1+ afferent terminals by capsaicin mediates long-lasting analgesia for trigeminal neuropathic pain","volume":"7","author":"Wang S","year":"2020","unstructured":"Wang S, Bian C, Yang J, Arora V, Gao Y, Wei F, Chung MK. Ablation of TRPV1+ afferent terminals by capsaicin mediates long-lasting analgesia for trigeminal neuropathic pain. eNeuro. 2020, 7:2. 10.1523\/ENEURO.0118-20.2020","journal-title":"eNeuro"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115806","article-title":"Progress in the development of TRPV1 small-molecule antagonists: novel strategies for pain management","volume":"261","author":"Zhu K","year":"2023","unstructured":"Zhu K, Wang L, Liao T, Li W, Zhou J, You Y, Shi J. Progress in the development of TRPV1 small-molecule antagonists: novel strategies for pain management. Eur J Med Chem. 2023, 261:6. 10.1016\/j.ejmech.2023.115806","journal-title":"Eur J Med Chem"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2019.105110","article-title":"Analgesic and antipruritic effects of oxymatrine sustained-release microgel cream in a mouse model of inflammatory itch and pain","volume":"141","author":"Zhu T","year":"2020","unstructured":"Zhu T, Zhou D, Zhang Z, et al.. Analgesic and antipruritic effects of oxymatrine sustained-release microgel cream in a mouse model of inflammatory itch and pain. Eur J Pharm Sci. 2020, 141:105110. 10.1016\/j.ejps.2019.105110","journal-title":"Eur J Pharm Sci"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2006.04.007","article-title":"Attenuation of experimental arthritis in TRPV1R knockout mice","volume":"81","author":"Barton NJ","year":"2006","unstructured":"Barton NJ, McQueen DS, Thomson D, Gauldie SD, Wilson AW, Salter DM, Chessell IP. Attenuation of experimental arthritis in TRPV1R knockout mice. Exp Mol Pathol. 2006, 81:166-70. 10.1016\/j.yexmp.2006.04.007","journal-title":"Exp Mol Pathol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2005.06.024","article-title":"Investigation of the role of TRPV1 receptors in acute and chronic nociceptive processes using gene-deficient mice","volume":"117","author":"B\u00f6lcskei K","year":"2005","unstructured":"B\u00f6lcskei K, Helyes Z, Szab\u00f3 \u00c1, et al.. Investigation of the role of TRPV1 receptors in acute and chronic nociceptive processes using gene-deficient mice. Pain. 2005, 117:368-76. 10.1016\/j.pain.2005.06.024","journal-title":"Pain"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aac6589","article-title":"CT-guided injection of a TRPV1 agonist around dorsal root ganglia decreases pain transmission in swine","volume":"7","author":"Brown JD","year":"2015","unstructured":"Brown JD, Saeed M, Do L, et al.. CT-guided injection of a TRPV1 agonist around dorsal root ganglia decreases pain transmission in swine. Sci Transl Med. 2015, 7:145. 10.1126\/scitranslmed.aac6589","journal-title":"Sci Transl Med"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15292","article-title":"TRPV1 channels are critical brain inflammation detectors and neuropathic pain biomarkers in mice","volume":"8","author":"Marrone MC","year":"2017","unstructured":"Marrone MC, Morabito A, Giustizieri M, et al.. TRPV1 channels are critical brain inflammation detectors and neuropathic pain biomarkers in mice. Nat Commun. 2017, 8:15292. 10.1038\/ncomms15292","journal-title":"Nat Commun"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.910885","article-title":"Effect of bufalin-PLGA microspheres in the alleviation of neuropathic pain via the CCI model","volume":"13","author":"Long L","year":"2022","unstructured":"Long L, Zhong W, Guo L, Ji J, Nie H. Effect of bufalin-PLGA microspheres in the alleviation of neuropathic pain via the CCI model. Front Pharmacol. 2022, 13:5. 10.3389\/fphar.2022.910885","journal-title":"Front Pharmacol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2010.11.015","article-title":"A novel human volunteer pain model using contact heat evoked potentials (CHEP) following topical skin application of transient receptor potential agonists capsaicin, menthol and cinnamaldehyde","volume":"18","author":"Roberts K","year":"2011","unstructured":"Roberts K, Shenoy R, Anand P. A novel human volunteer pain model using contact heat evoked potentials (CHEP) following topical skin application of transient receptor potential agonists capsaicin, menthol and cinnamaldehyde. J Clin Neurosci. 2011, 18:926-32. 10.1016\/j.jocn.2010.11.015","journal-title":"J Clin Neurosci"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2007.08.035","article-title":"Transient receptor potential V2 expressed in sensory neurons is activated by probenecid","volume":"425","author":"Bang S","year":"2007","unstructured":"Bang S, Kim KY, Yoo S, Lee SH, Hwang SW. Transient receptor potential V2 expressed in sensory neurons is activated by probenecid. Neurosci Lett. 2007, 425:120-5. 10.1016\/j.neulet.2007.08.035","journal-title":"Neurosci Lett"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2016.10.002","article-title":"Transient receptor potential channels in neuropathic pain","volume":"32","author":"Basso L","year":"2017","unstructured":"Basso L, Altier C. Transient receptor potential channels in neuropathic pain. Curr Opin Pharmacol. 2017, 32:9-15. 10.1016\/j.coph.2016.10.002","journal-title":"Curr Opin Pharmacol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-13-1756-9_2","article-title":"TRP channels in nociception and pathological pain","volume":"1099","author":"Hung CY","year":"2018","unstructured":"Hung CY, Tan CH. TRP channels in nociception and pathological pain. Adv Exp Med Biol. 2018, 1099:13-27. 10.1007\/978-981-13-1756-9_2","journal-title":"Adv Exp Med Biol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1186\/1744-8069-5-19","article-title":"Pharmacological blockade of TRPA1 inhibits mechanical firing in nociceptors","volume":"5","author":"Kerstein PC","year":"2009","unstructured":"Kerstein PC, del Camino D, Moran MM, Stucky CL. Pharmacological blockade of TRPA1 inhibits mechanical firing in nociceptors. Mol Pain. 2009, 5:19. 10.1186\/1744-8069-5-19","journal-title":"Mol Pain"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S41614","article-title":"Comparison of the transport of QX-314 through TRPA1, TRPM8, and TRPV1 channels","volume":"6","author":"Nakagawa H","year":"2013","unstructured":"Nakagawa H, Hiura A. Comparison of the transport of QX-314 through TRPA1, TRPM8, and TRPV1 channels. J Pain Res. 2013, 6:223-30. 10.2147\/JPR.S41614","journal-title":"J Pain Res"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000001298","article-title":"Psychophysical and vasomotor evidence for interdependency of TRPA1 and TRPV1-evoked nociceptive responses in human skin: an experimental study","volume":"159","author":"Nielsen TA","year":"2018","unstructured":"Nielsen TA, Eriksen MA, Gazerani P, Andersen HH. Psychophysical and vasomotor evidence for interdependency of TRPA1 and TRPV1-evoked nociceptive responses in human skin: an experimental study. Pain. 2018, 159:1989-2001. 10.1097\/j.pain.0000000000001298","journal-title":"Pain"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.2174\/1568007043336789","article-title":"Nociception and TRP channels","volume":"3","author":"Numazaki M","year":"2004","unstructured":"Numazaki M, Tominaga M. Nociception and TRP channels. Curr Drug Targets CNS Neurol Disord. 2004, 3:479-85. 10.2174\/1568007043336789","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2014.12.065","article-title":"Tmem100 is a regulator of TRPA1-TRPV1 complex and contributes to persistent pain","volume":"85","author":"Weng HJ","year":"2015","unstructured":"Weng HJ, Patel KN, Jeske NA, et al.. Tmem100 is a regulator of TRPA1-TRPV1 complex and contributes to persistent pain. Neuron. 2015, 85:833-46. 10.1016\/j.neuron.2014.12.065","journal-title":"Neuron"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2018.06.020","article-title":"Human pharmacological approaches to TRP-ion-channel-based analgesic drug development","volume":"23","author":"Weyer-Menkhoff I","year":"2018","unstructured":"Weyer-Menkhoff I, L\u00f6tsch J. Human pharmacological approaches to TRP-ion-channel-based analgesic drug development. Drug Discov Today. 2018, 23:2003-12. 10.1016\/j.drudis.2018.06.020","journal-title":"Drug Discov Today"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2007.06.006","article-title":"The effects of the TRPV1 antagonist SB-705498 on TRPV1 receptor-mediated activity and inflammatory hyperalgesia in humans","volume":"132","author":"Chizh BA","year":"2007","unstructured":"Chizh BA, O'Donnell MB, Napolitano A, et al.. The effects of the TRPV1 antagonist SB-705498 on TRPV1 receptor-mediated activity and inflammatory hyperalgesia in humans. Pain. 2007, 132:132-41. 10.1016\/j.pain.2007.06.006","journal-title":"Pain"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-12717-5","article-title":"Supraspinal-selective TRPV1 desensitization induced by intracerebroventricular treatment with resiniferatoxin","volume":"7","author":"Fukushima A","year":"2017","unstructured":"Fukushima A, Mamada K, Iimura A, Ono H. Supraspinal-selective TRPV1 desensitization induced by intracerebroventricular treatment with resiniferatoxin. Sci Rep. 2017, 7:12452. 10.1038\/s41598-017-12717-5","journal-title":"Sci Rep"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2008.11.001","article-title":"Beta2-microglobulin: emerging as a promising cancer therapeutic target","volume":"14","author":"Shi C","year":"2009","unstructured":"Shi C, Zhu Y, Su Y, Chung LW, Cheng T. Beta2-microglobulin: emerging as a promising cancer therapeutic target. Drug Discov Today. 2009, 14:25-30. 10.1016\/j.drudis.2008.11.001","journal-title":"Drug Discov Today"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.2174\/156802611796904942","article-title":"The vanilloid agonist resiniferatoxin for interventional-based pain control","volume":"11","author":"Iadarola MJ","year":"2011","unstructured":"Iadarola MJ, Mannes AJ. The vanilloid agonist resiniferatoxin for interventional-based pain control. Curr Top Med Chem. 2011, 11:2171-9. 10.2174\/156802611796904942","journal-title":"Curr Top Med Chem"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/2786427","article-title":"Intrathecal resiniferatoxin modulates TRPV1 in DRG neurons and reduces TNF-induced pain-related behavior","volume":"2017","author":"Leo M","year":"2017","unstructured":"Leo M, Schulte M, Schmitt LI, Sch\u00e4fers M, Kleinschnitz C, Hagenacker T. Intrathecal resiniferatoxin modulates TRPV1 in DRG neurons and reduces TNF-induced pain-related behavior. Mediators Inflamm. 2017, 2017:7. 10.1155\/2017\/2786427","journal-title":"Mediators Inflamm"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e318260de41","article-title":"Differential effects of peripheral versus central coadministration of QX-314 and capsaicin on neuropathic pain in rats","volume":"117","author":"Shen J","year":"2012","unstructured":"Shen J, Fox LE, Cheng J. Differential effects of peripheral versus central coadministration of QX-314 and capsaicin on neuropathic pain in rats. Anesthesiology. 2012, 117:365-80. 10.1097\/ALN.0b013e318260de41","journal-title":"Anesthesiology"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2014.01.021","article-title":"The anticancer antibiotic mithramycin-A inhibits TRPV1 expression in dorsal root ganglion neurons","volume":"578","author":"Zavala K","year":"2014","unstructured":"Zavala K, Lee J, Chong J, Sharma M, Eilers H, Schumacher MA. The anticancer antibiotic mithramycin-A inhibits TRPV1 expression in dorsal root ganglion neurons. Neurosci Lett. 2014, 578:211-6. 10.1016\/j.neulet.2014.01.021","journal-title":"Neurosci Lett"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1007\/s10571-014-0041-1","article-title":"Inhibitory effects of capsaicin on voltage-gated potassium channels by TRPV1-independent pathway","volume":"34","author":"Yang R","year":"2014","unstructured":"Yang R, Xiong Z, Liu C, Liu L. Inhibitory effects of capsaicin on voltage-gated potassium channels by TRPV1-independent pathway. Cell Mol Neurobiol. 2014, 34:565-76. 10.1007\/s10571-014-0041-1","journal-title":"Cell Mol Neurobiol"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0100610","article-title":"A randomised trial evaluating the effects of the TRPV1 antagonist SB705498 on pruritus induced by histamine, and cowhage challenge in healthy volunteers","volume":"9","author":"Gibson RA","year":"2014","unstructured":"Gibson RA, Robertson J, Mistry H, McCallum S, Fernando D, Wyres M, Yosipovitch G. A randomised trial evaluating the effects of the TRPV1 antagonist SB705498 on pruritus induced by histamine, and cowhage challenge in healthy volunteers. PLoS One. 2014, 9:e100610. 10.1371\/journal.pone.0100610","journal-title":"PLoS One"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007393.pub4","article-title":"Topical capsaicin (high concentration) for chronic neuropathic pain in adults","volume":"1","author":"Derry S","year":"2017","unstructured":"Derry S, Rice AS, Cole P, Tan T, Moore RA. Topical capsaicin (high concentration) for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2017, 1:CD007393. 10.1002\/14651858.CD007393.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.172934","article-title":"In vitro characterization of the thermoneutral transient receptor potential vanilloid-1 (TRPV1) inhibitor GRTE16523","volume":"871","author":"Damann N","year":"2020","unstructured":"Damann N, Bahrenberg G, Stockhausen H, et al.. In vitro characterization of the thermoneutral transient receptor potential vanilloid-1 (TRPV1) inhibitor GRTE16523. Eur J Pharmacol. 2020, 871:4. 10.1016\/j.ejphar.2020.172934","journal-title":"Eur J Pharmacol"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1002\/ejp.2017","article-title":"Role of Src kinase in regulating protein kinase C mediated phosphorylation of TRPV1","volume":"26","author":"Robilotto GL","year":"2022","unstructured":"Robilotto GL, Mohapatra DP, Shepherd AJ, Mickle AD. Role of Src kinase in regulating protein kinase C mediated phosphorylation of TRPV1. Eur J Pain. 2022, 26:1967-78. 10.1002\/ejp.2017","journal-title":"Eur J Pain"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.2174\/156802611796904843","article-title":"TRPV1 signaling: mechanistic understanding and therapeutic potential","volume":"11","author":"Xia R","year":"2011","unstructured":"Xia R, Samad TA, Btesh J, Jiang LH, Kays I, Stjernborg L, Dekker N. TRPV1 signaling: mechanistic understanding and therapeutic potential. Curr Top Med Chem. 2011, 11:2180-91. 10.2174\/156802611796904843","journal-title":"Curr Top Med Chem"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2013.03.003","article-title":"Targeting TRP channels for pain relief","volume":"716","author":"Brederson JD","year":"2013","unstructured":"Brederson JD, Kym PR, Szallasi A. Targeting TRP channels for pain relief. Eur J Pharmacol. 2013, 716:61-76. 10.1016\/j.ejphar.2013.03.003","journal-title":"Eur J Pharmacol"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.107.125674","article-title":"Repeated administration of vanilloid receptor TRPV1 antagonists attenuates hyperthermia elicited by TRPV1 blockade","volume":"323","author":"Gavva NR","year":"2007","unstructured":"Gavva NR, Bannon AW, Hovland DN Jr, et al.. Repeated administration of vanilloid receptor TRPV1 antagonists attenuates hyperthermia elicited by TRPV1 blockade. J Pharmacol Exp Ther. 2007, 323:128-37. 10.1124\/jpet.107.125674","journal-title":"J Pharmacol Exp Ther"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2024.02.016","article-title":"TRPV1 analgesics disturb core body temperature via a biased allosteric mechanism involving conformations distinct from that for nociception","volume":"112","author":"Huang YZ","year":"2024","unstructured":"Huang YZ, Ma JX, Bian YJ, et al.. TRPV1 analgesics disturb core body temperature via a biased allosteric mechanism involving conformations distinct from that for nociception. Neuron. 2024, 112:1815-31.e4. 10.1016\/j.neuron.2024.02.016","journal-title":"Neuron"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.2174\/156802611796904924","article-title":"Therapeutic targeting of TRPV1 by resiniferatoxin, from preclinical studies to clinical trials","volume":"11","author":"Kissin I","year":"2011","unstructured":"Kissin I, Szallasi A. Therapeutic targeting of TRPV1 by resiniferatoxin, from preclinical studies to clinical trials. Curr Top Med Chem. 2011, 11:2159-70. 10.2174\/156802611796904924","journal-title":"Curr Top Med Chem"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1007\/978-94-007-0265-3_27","article-title":"Complex regulation of TRPV1 and related thermo-TRPs: implications for therapeutic intervention","volume":"704","author":"Planells-Cases R","year":"2011","unstructured":"Planells-Cases R, Valente P, Ferrer-Montiel A, Qin F, Szallasi A. Complex regulation of TRPV1 and related thermo-TRPs: implications for therapeutic intervention. Adv Exp Med Biol. 2011, 704:491-515. 10.1007\/978-94-007-0265-3_27","journal-title":"Adv Exp Med Biol"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.80139","article-title":"TRPV1 drugs alter core body temperature via central projections of primary afferent sensory neurons","volume":"11","author":"Yue WW","year":"2022","unstructured":"Yue WW, Yuan L, Braz JM, Basbaum AI, Julius D. TRPV1 drugs alter core body temperature via central projections of primary afferent sensory neurons. Elife. 2022, 11:9. 10.7554\/eLife.80139","journal-title":"Elife"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2019.04.010","article-title":"Chalcone derivatives as non-canonical ligands of TRPV1","volume":"112","author":"Benso B","year":"2019","unstructured":"Benso B, Bustos D, Zarraga MO, Gonzalez W, Caballero J, Brauchi S. Chalcone derivatives as non-canonical ligands of TRPV1. Int J Biochem Cell Biol. 2019, 112:18-23. 10.1016\/j.biocel.2019.04.010","journal-title":"Int J Biochem Cell Biol"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2008.04.043","article-title":"Vanilloid receptor TRPV1-positive sensory afferents in the mouse ankle and knee joints","volume":"1219","author":"Cho WG","year":"2008","unstructured":"Cho WG, Valtschanoff JG. Vanilloid receptor TRPV1-positive sensory afferents in the mouse ankle and knee joints. Brain Res. 2008, 1219:59-65. 10.1016\/j.brainres.2008.04.043","journal-title":"Brain Res"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.2005.04227.x","article-title":"Inhibition of peripheral vanilloid TRPV1 receptors reduces noxious heat-evoked responses of dorsal horn neurons in na\u00efve, carrageenan-inflamed and neuropathic rats","volume":"22","author":"Jhaveri MD","year":"2005","unstructured":"Jhaveri MD, Elmes SJ, Kendall DA, Chapman V. Inhibition of peripheral vanilloid TRPV1 receptors reduces noxious heat-evoked responses of dorsal horn neurons in na\u00efve, carrageenan-inflamed and neuropathic rats. Eur J Neurosci. 2005, 22:361-70. 10.1111\/j.1460-9568.2005.04227.x","journal-title":"Eur J Neurosci"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1186\/1744-8069-6-58","article-title":"Cutaneous C-polymodal fibers lacking TRPV1 are sensitized to heat following inflammation, but fail to drive heat hyperalgesia in the absence of TPV1 containing C-heat fibers","volume":"6","author":"Koerber HR","year":"2010","unstructured":"Koerber HR, McIlwrath SL, Lawson JJ, Malin SA, Anderson CE, Jankowski MP, Davis BM. Cutaneous C-polymodal fibers lacking TRPV1 are sensitized to heat following inflammation, but fail to drive heat hyperalgesia in the absence of TPV1 containing C-heat fibers. Mol Pain. 2010, 6:58. 10.1186\/1744-8069-6-58","journal-title":"Mol Pain"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1254\/jphs.13088fp","article-title":"K-685, a TRPV1 antagonist, blocks PKC-sensitized TRPV1 activation and improves the inflammatory pain in a rat complete Freund's adjuvant model","volume":"123","author":"Sugimoto Y","year":"2013","unstructured":"Sugimoto Y, Kojima Y, Inayoshi A, et al.. K-685, a TRPV1 antagonist, blocks PKC-sensitized TRPV1 activation and improves the inflammatory pain in a rat complete Freund's adjuvant model. J Pharmacol Sci. 2013, 123:256-66. 10.1254\/jphs.13088fp","journal-title":"J Pharmacol Sci"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2012.04.034","article-title":"TRPV1 is important for mechanical and heat sensitivity in uninjured animals and development of heat hypersensitivity after muscle inflammation","volume":"153","author":"Walder RY","year":"2012","unstructured":"Walder RY, Radhakrishnan R, Loo L, Rasmussen LA, Mohapatra DP, Wilson SP, Sluka KA. TRPV1 is important for mechanical and heat sensitivity in uninjured animals and development of heat hypersensitivity after muscle inflammation. Pain. 2012, 153:1664-72. 10.1016\/j.pain.2012.04.034","journal-title":"Pain"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2007.03.003","article-title":"TRP channels and pain","volume":"1772","author":"Cortright DN","year":"2007","unstructured":"Cortright DN, Krause JE, Broom DC. TRP channels and pain. Biochim Biophys Acta. 2007, 1772:978-88. 10.1016\/j.bbadis.2007.03.003","journal-title":"Biochim Biophys Acta"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.111.183053","article-title":"Small molecule positive allosteric modulation of TRPV1 activation by vanilloids and acidic pH","volume":"340","author":"Kaszas K","year":"2012","unstructured":"Kaszas K, Keller JM, Coddou C, et al.. Small molecule positive allosteric modulation of TRPV1 activation by vanilloids and acidic pH. J Pharmacol Exp Ther. 2012, 340:152-60. 10.1124\/jpet.111.183053","journal-title":"J Pharmacol Exp Ther"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics11010014","article-title":"Development of a new delivery system based on drug-loadable electrospun nanofibers for psoriasis treatment","volume":"11","author":"Mart\u00ednez-Ortega L","year":"2019","unstructured":"Mart\u00ednez-Ortega L, Mira A, Fernandez-Carvajal A, Mateo CR, Mallavia R, Falco A. Development of a new delivery system based on drug-loadable electrospun nanofibers for psoriasis treatment. Pharmaceutics. 2019, 11:4. 10.3390\/pharmaceutics11010014","journal-title":"Pharmaceutics"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.391847","article-title":"\u03b2-Arrestin-2 desensitizes the transient receptor potential vanilloid 1 (TRPV1) channel","volume":"287","author":"Por ED","year":"2012","unstructured":"Por ED, Bierbower SM, Berg KA, Gomez R, Akopian AN, Wetsel WC, Jeske NA. \u03b2-Arrestin-2 desensitizes the transient receptor potential vanilloid 1 (TRPV1) channel. J Biol Chem. 2012, 287:37552-63. 10.1074\/jbc.M112.391847","journal-title":"J Biol Chem"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.2741\/3651","article-title":"TRPV1 splice variants: structure and function","volume":"15","author":"Schumacher MA","year":"2010","unstructured":"Schumacher MA, Eilers H. TRPV1 splice variants: structure and function. Front Biosci (Landmark Ed). 2010, 15:872-82. 10.2741\/3651","journal-title":"Front Biosci (Landmark Ed)"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-39184-4","article-title":"Silencing of spinal Trpv1 attenuates neuropathic pain in rats by inhibiting CAMKII expression and ERK2 phosphorylation","volume":"9","author":"Guo SH","year":"2019","unstructured":"Guo SH, Lin JP, Huang LE, et al.. Silencing of spinal Trpv1 attenuates neuropathic pain in rats by inhibiting CAMKII expression and ERK2 phosphorylation. Sci Rep. 2019, 9:2769. 10.1038\/s41598-019-39184-4","journal-title":"Sci Rep"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1007\/s00482-005-0440-9","article-title":"The capsaicin receptor. \"TRPing\" transduction for painful stimuli","volume":"20","author":"Greffrath W","year":"2006","unstructured":"Greffrath W. The capsaicin receptor. \"TRPing\" transduction for painful stimuli. Schmerz. 2006, 20:219-25. 10.1007\/s00482-005-0440-9","journal-title":"Schmerz"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.2174\/157015906778019554","article-title":"Inflammatory pain: the cellular basis of heat hyperalgesia","volume":"4","author":"Huang J","year":"2006","unstructured":"Huang J, Zhang X, McNaughton PA. Inflammatory pain: the cellular basis of heat hyperalgesia. Curr Neuropharmacol. 2006, 4:197-206. 10.2174\/157015906778019554","journal-title":"Curr Neuropharmacol"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2013.07.021","article-title":"Resiniferatoxin (RTX) causes a uniquely protracted musculoskeletal hyperalgesia in mice by activation of TRPV1 receptors","volume":"14","author":"Abdelhamid RE","year":"2013","unstructured":"Abdelhamid RE, Kov\u00e1cs KJ, Honda CN, Nunez MG, Larson AA. Resiniferatoxin (RTX) causes a uniquely protracted musculoskeletal hyperalgesia in mice by activation of TRPV1 receptors. J Pain. 2013, 14:1629-41. 10.1016\/j.jpain.2013.07.021","journal-title":"J Pain"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1517288113","article-title":"Understanding TRPV1 activation by ligands: insights from the binding modes of capsaicin and resiniferatoxin","volume":"113","author":"Elokely K","year":"2016","unstructured":"Elokely K, Velisetty P, Delemotte L, Palovcak E, Klein ML, Rohacs T, Carnevale V. Understanding TRPV1 activation by ligands: insights from the binding modes of capsaicin and resiniferatoxin. Proc Natl Acad Sci U S A. 2016, 113:E137-45. 10.1073\/pnas.1517288113","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2016.00178","article-title":"Bradykinin induces TRPV1 exocytotic recruitment in peptidergic nociceptors","volume":"7","author":"Mathivanan S","year":"2016","unstructured":"Mathivanan S, Devesa I, Changeux JP, Ferrer-Montiel A. Bradykinin induces TRPV1 exocytotic recruitment in peptidergic nociceptors. Front Pharmacol. 2016, 7:178. 10.3389\/fphar.2016.00178","journal-title":"Front Pharmacol"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/1512457","article-title":"Integrating TRPV1 receptor function with capsaicin psychophysics","volume":"2016","author":"Smutzer G","year":"2016","unstructured":"Smutzer G, Devassy RK. Integrating TRPV1 receptor function with capsaicin psychophysics. Adv Pharmacol Sci. 2016, 2016:7. 10.1155\/2016\/1512457","journal-title":"Adv Pharmacol Sci"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1186\/1744-8069-4-61","article-title":"The role of TRPV1 in different subtypes of dorsal root ganglion neurons in rat chronic inflammatory nociception induced by complete Freund's adjuvant","volume":"4","author":"Yu L","year":"2008","unstructured":"Yu L, Yang F, Luo H, Liu FY, Han JS, Xing GG, Wan Y. The role of TRPV1 in different subtypes of dorsal root ganglion neurons in rat chronic inflammatory nociception induced by complete Freund's adjuvant. Mol Pain. 2008, 4:61. 10.1186\/1744-8069-4-61","journal-title":"Mol Pain"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.3390\/ph9030047","article-title":"Resiniferatoxin: the evolution of the \"molecular scalpel\" for chronic pain relief","volume":"9","author":"Brown DC","year":"2016","unstructured":"Brown DC. Resiniferatoxin: the evolution of the \"molecular scalpel\" for chronic pain relief. Pharmaceuticals (Basel). 2016, 9:7. 10.3390\/ph9030047","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.2174\/156802611796904898","article-title":"Therapeutic targeting of TRP channels - the TR(i)P to pain relief","volume":"11","author":"Eid SR","year":"2011","unstructured":"Eid SR. Therapeutic targeting of TRP channels - the TR(i)P to pain relief. Curr Top Med Chem. 2011, 11:2118-30. 10.2174\/156802611796904898","journal-title":"Curr Top Med Chem"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-020-01429-2","article-title":"TRPV1-targeted drugs in development for human pain conditions","volume":"81","author":"Iftinca M","year":"2021","unstructured":"Iftinca M, Defaye M, Altier C. TRPV1-targeted drugs in development for human pain conditions. Drugs. 2021, 81:7-27. 10.1007\/s40265-020-01429-2","journal-title":"Drugs"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1016\/s1567-7443(08)10404-5","article-title":"Molecular mechanisms of TRPV1-mediated pain","volume":"75","author":"Nagy I","year":"2009","unstructured":"Nagy I, Paule CC, White JPM. Molecular mechanisms of TRPV1-mediated pain. Neuroimmunol Biol. 2009, 75:99. 10.1016\/s1567-7443(08)10404-5","journal-title":"Neuroimmunol Biol"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.2174\/138920111793937826","article-title":"A \"cute\" desensitization of TRPV1","volume":"12","author":"Touska F","year":"2011","unstructured":"Touska F, Marsakova L, Teisinger J, Vlachova V. A \"cute\" desensitization of TRPV1. Curr Pharm Biotechnol. 2011, 12:122-9. 10.2174\/138920111793937826","journal-title":"Curr Pharm Biotechnol"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.3390\/ijms251910234","article-title":"Update on the role of \u03b22AR and TRPV1 in respiratory diseases","volume":"25","author":"Manti S","year":"2024","unstructured":"Manti S, Gambadauro A, Galletta F, Ruggeri P, Piedimonte G. Update on the role of \u03b22AR and TRPV1 in respiratory diseases. Int J Mol Sci. 2024, 25:4. 10.3390\/ijms251910234","journal-title":"Int J Mol Sci"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharep.2014.06.011","article-title":"Role of TRPV1 and ASIC3 in formalin-induced secondary allodynia and hyperalgesia","volume":"66","author":"Mart\u00ednez-Rojas VA","year":"2014","unstructured":"Mart\u00ednez-Rojas VA, Barrag\u00e1n-Iglesias P, Rocha-Gonz\u00e1lez HI, Murbarti\u00e1n J, Granados-Soto V. Role of TRPV1 and ASIC3 in formalin-induced secondary allodynia and hyperalgesia. Pharmacol Rep. 2014, 66:964-71. 10.1016\/j.pharep.2014.06.011","journal-title":"Pharmacol Rep"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1517\/17460440802681300","article-title":"Screening TRPV1 antagonists for the treatment of pain: lessons learned over a decade","volume":"4","author":"L\u00e1z\u00e1r J","year":"2009","unstructured":"L\u00e1z\u00e1r J, Gharat L, Khairathkar-Joshi N, Blumberg PM, Szallasi A. Screening TRPV1 antagonists for the treatment of pain: lessons learned over a decade. Expert Opin Drug Discov. 2009, 4:159-80. 10.1517\/17460440802681300","journal-title":"Expert Opin Drug Discov"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1021\/jm7014638","article-title":"Design and synthesis of peripherally restricted transient receptor potential vanilloid 1 (TRPV1) antagonists","volume":"51","author":"Tamayo N","year":"2008","unstructured":"Tamayo N, Liao H, Stec MM, et al.. Design and synthesis of peripherally restricted transient receptor potential vanilloid 1 (TRPV1) antagonists. J Med Chem. 2008, 51:2744-57. 10.1021\/jm7014638","journal-title":"J Med Chem"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/476986-gatekeepers-of-pain-a-scoping-review-on-how-nanoparticle-engineering-illuminates-selective-transient-receptor-potential-vanilloid-1-trpv1-targeting","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T22:51:54Z","timestamp":1776984714000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/476986-gatekeepers-of-pain-a-scoping-review-on-how-nanoparticle-engineering-illuminates-selective-transient-receptor-potential-vanilloid-1-trpv1-targeting"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,23]]},"references-count":102,"URL":"https:\/\/doi.org\/10.7759\/cureus.107610","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,23]]}}}